Stryker, founded in Michigan in 1941, is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in medical and surgical, neurotechnology, othopaedics and spine treatment that help improve patient outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients per year.
Stryker’s journey in Ireland began in 1998 with the establishment of its first operations in Carrigtwohill, Cork. The company initially set up manufacturing facilities for orthopaedic implants and medical instruments. Within that same year, Stryker Ireland expanded by acquiring Pfizer’s Howmedica business and incorporating the Limerick ortho manufacturing facility.
Since its inception in Ireland, Stryker has experienced continuous growth through both organic expansion and strategic acquisitions. Presently, the company boasts eight sites in Ireland, including two Global R&D innovation centres. Notably, the AMagine Institute, inaugurated in 2016, holds the distinction of being the world’s largest 3D printing facility for medical devices. In 2022, the Angrove facility further expanded with the opening of a state-of-the-art 156,000 sq ft facility, creating 600 new jobs.
With exponential growth across the eight dedicated sites in Ireland, Stryker now employs over 5,000 people directly. Stryker’s Irish research and development (R&D) workforce contributes significantly to a diverse medical technology portfolio, spanning from stroke care to hip implants, surgical instruments, and customised 3D-printed devices.
Ireland is home to Stryker’s European Operations headquarters. The Irish facilities recently achieved milestones, celebrating the production of one million Triathlon knees and marking a decade of success in 3D printed cementless tibial baseplate manufacturing.
Stryker’s success story in Ireland over the past 25 years is testament to the fruitful partnership between Stryker and the Irish government, particularly IDA Ireland. This collaboration has expanded Stryker's focus from initial manufacturing to include innovation in key strategic areas like next-generation manufacturing technologies, 3D printing, and manufacturing digitisation.
The support, coupled with key government policies, has paved the way for Stryker’s significant achievements, showcasing Ireland as an attractive destination for companies engaged in cutting-edge R&D activities. Stryker’s Irish operations represent the company’s largest innovation and manufacturing hub outside the USA.
Stryker’s Irish operations, with a culture of innovation and state-of-the-art facilities, have helped secure Ireland’s position as a global epicentre for medical technology development.
Stryker's presence in Ireland is more than just a business expansion; it's a journey of mutual growth, skills development, and technological innovation that helps position Ireland as a global hub for leading innovation in the medical technology industry.